Baxter International, Inc. has completed the acquisition of Gambro AB, a global medical technology company based in Lund, Sweden, for approximately $3.9 billion, expanding its global renal business and gaining a comprehensive portfolio of product and therapies.   The acquisition provides a broad dialysis product portfolio and global footprint that will allow Baxter to grow product sales in Europe, where Gambro has an extensive presence, as well as Latin America and Asia-Pacific.   Brik Eyre has ...